We’ve got your HR challenges covered

New Year, New DOT Testing Panel Requirements

Do you have DOT covered employees? If you do, starting 1/1/2018 DOT testing panel requirements have been changed to include synthetic opioids (hydrocodone, oxycodone, hydromorphone, and oxymorphone).  Some common names for these synthetic opioids include OxyContin, Percodan, Percocet, Vicodin, Lortab, Norco, Dilaudid and Exalgo.

An employee who has a legitimate prescription, and who obtains the drug from a licensed pharmacy, will not be in violation and will not require a SAP return-to-duty process.  But if the employee doesn’t have a legitimate prescription, the MRO can assume the employee is using illegal street drugs, and the employee be in DOT violation.

If your DOT policies identify drugs in the DOT testing panel, you must include synthetic opiates to that list. Make sure the lab you use for DOT drug testing includes synthetic opioids in its DOT panel.

If you have questions regarding this new requirement please contact your Ulliance Account Manager  877.912.2733